Daisuke Morihara

567 total citations
48 papers, 349 citations indexed

About

Daisuke Morihara is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Daisuke Morihara has authored 48 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hepatology, 25 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Daisuke Morihara's work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Daisuke Morihara is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Daisuke Morihara collaborates with scholars based in Japan. Daisuke Morihara's co-authors include Shotaro Sakisaka, Keiji Yokoyama, Satoshi Shakado, Yasuaki Takeyama, Takashi Tanaka, Makoto Irie, Tetsuro Sohda, Kazuhide Takata, Akira Anan and Ryo Yamauchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Journal of Gastroenterology and Hepatology.

In The Last Decade

Daisuke Morihara

46 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Morihara Japan 11 206 201 80 67 49 48 349
Akira Anan Japan 12 271 1.3× 274 1.4× 120 1.5× 57 0.9× 74 1.5× 33 432
Shigeo Maruyama Japan 9 188 0.9× 182 0.9× 58 0.7× 46 0.7× 46 0.9× 25 378
Kota Tsuruya Japan 13 175 0.8× 206 1.0× 99 1.2× 77 1.1× 60 1.2× 46 408
Virginia Knight Australia 10 200 1.0× 210 1.0× 35 0.4× 42 0.6× 32 0.7× 15 313
Weijia Duan China 12 206 1.0× 223 1.1× 135 1.7× 34 0.5× 50 1.0× 33 388
Evangelia Fatourou United Kingdom 13 149 0.7× 223 1.1× 93 1.2× 87 1.3× 38 0.8× 20 351
Naotaka Shimozato Japan 13 177 0.9× 158 0.8× 58 0.7× 26 0.4× 70 1.4× 34 342
Yuki Tsuji Japan 14 198 1.0× 154 0.8× 125 1.6× 44 0.7× 100 2.0× 43 450
Wei‐Fan Hsu Taiwan 12 193 0.9× 220 1.1× 90 1.1× 49 0.7× 32 0.7× 45 365
Hyun Yang South Korea 14 152 0.7× 238 1.2× 67 0.8× 86 1.3× 43 0.9× 40 398

Countries citing papers authored by Daisuke Morihara

Since Specialization
Citations

This map shows the geographic impact of Daisuke Morihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Morihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Morihara more than expected).

Fields of papers citing papers by Daisuke Morihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Morihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Morihara. The network helps show where Daisuke Morihara may publish in the future.

Co-authorship network of co-authors of Daisuke Morihara

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Morihara. A scholar is included among the top collaborators of Daisuke Morihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Morihara. Daisuke Morihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morihara, Daisuke, Satoshi Shakado, Keiji Yokoyama, et al.. (2023). Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study. Intestinal Research. 21(4). 471–480. 1 indexed citations
2.
Yamauchi, Ryo, Hidetoshi Takedatsu, Keiji Yokoyama, et al.. (2021). Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice. Hepatology International. 15(2). 392–404. 15 indexed citations
3.
Yokoyama, Keiji, Hiromi Fukuda, Ryo Yamauchi, et al.. (2021). Novel Endoscopic Therapy for Gastric Varices Using Direct Forward-Viewing Endoscopic Ultrasonography. SHILAP Revista de lepidopterología. 15(1). 28–34. 3 indexed citations
4.
5.
Shakado, Satoshi, Takashi Tanaka, Kazuhide Takata, et al.. (2020). Reduction in Tumor Stain at 2 Weeks after Treatment Initiation Is a Predictor of the Efficacy of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma. Oncology. 98(11). 779–786. 4 indexed citations
6.
Takata, Kazuhide, Satoshi Shakado, Yoshinari Uehara, et al.. (2020). Horizontal Transmission of Hepatitis B Virus Genotype C Among Members of a Wrestling Club in Japan. American Journal of Case Reports. 21. e925044–e925044. 3 indexed citations
7.
Yokoyama, Keiji, Ryo Yamauchi, Hiromi Fukuda, et al.. (2018). Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis. Clinical and Molecular Hepatology. 25(2). 183–189. 7 indexed citations
8.
Takata, Kazuhide, Satoshi Shakado, Hiromi Fukuda, et al.. (2017). Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C. Clinical Journal of Gastroenterology. 10(5). 459–463. 5 indexed citations
9.
Morihara, Daisuke, Takashi Tanaka, Keiji Yokoyama, et al.. (2017). Hepatic Pseudolymphoma with an Occult Hepatitis B Virus Infection. Internal Medicine. 57(2). 223–230. 11 indexed citations
10.
Iwata, Kaoru, Akira Anan, Tetsuro Sohda, et al.. (2015). Why is radiofrequency ablation therapy applied for hepatocellular carcinoma up to 3 nodules and smaller than 3 cm in tumor size?. PubMed. 61(136). 2305–10. 5 indexed citations
11.
Sohda, Tetsuro, Kaoru Iwata, Keiji Yokoyama, et al.. (2013). 3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemia. Medical Molecular Morphology. 46(4). 239–242. 8 indexed citations
12.
Yokoyama, Keiji, Akira Anan, Kaoru Iwata, et al.. (2012). Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: Proposal of a three (times) ×  3 (years) index. Journal of Gastroenterology and Hepatology. 27(6). 1044–1050. 9 indexed citations
13.
Sohda, Tetsuro, Atsushi Fukunaga, H Iwashita, et al.. (2012). Systemic Chemotherapy Using Carboplatin and 5-Fluorouracil for Extrahepatic Metastasis of Hepatocellular Carcinoma. Hepatogastroenterology. 59(119). 2264–8. 4 indexed citations
14.
Shakado, Satoshi, Yuko Akehi, Atsushi Fukunaga, et al.. (2011). A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin. Clinical Journal of Gastroenterology. 4(4). 255–261. 3 indexed citations
15.
Irie, Makoto, Keiji Yokoyama, Daisuke Morihara, et al.. (2010). Patient with drug-induced hepatic injury with sever bilirubinemia due to long-term administration of Amlodipine and Loxoprofen Na. Kanzo. 51(4). 169–174.
16.
Morihara, Daisuke, Yasuaki Takeyama, Shinya Nishizawa, et al.. (2009). A Case of Acute Pancreatitis Associated with a Severe Acute HAV Infection and Compensated Liver Cirrhosis Type B. 36(2). 135–139. 1 indexed citations
17.
Morihara, Daisuke, Masahiro Kobayashi, Kenji Ikeda, et al.. (2009). Effectiveness of combination therapy of splenectomy and long‐term interferon in patients with hepatitis C virus‐related cirrhosis and thrombocytopenia. Hepatology Research. 39(5). 439–447. 36 indexed citations
18.
Tanaka, Takashi, Satoshi Shakado, Daisuke Morihara, et al.. (2008). The prognostic factors of sustained virologic response among patients of chronic hepatitis C treated with peg-interferon alpha 2a monotherapy. Kanzo. 49(9). 417–425. 3 indexed citations
19.
Takeyama, Yasuaki, Takashi Tanaka, Shuichi Ueda, et al.. (2008). Budd-Chiari Syndrome: Two Cases with Different Courses. Case Reports in Gastroenterology. 2(2). 256–261. 1 indexed citations
20.
Shakado, Satoshi, Hiroshi Watanabe, Takashi Tanaka, et al.. (2008). Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B. Hepatology International. 2(3). 361–369. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Anan Breakdown of academic impact, for papers by Shigeo Maruyama Breakdown of academic impact, for papers by Kota Tsuruya Breakdown of academic impact, for papers by Virginia Knight Breakdown of academic impact, for papers by Weijia Duan Breakdown of academic impact, for papers by Evangelia Fatourou Breakdown of academic impact, for papers by Naotaka Shimozato Breakdown of academic impact, for papers by Yuki Tsuji Breakdown of academic impact, for papers by Wei‐Fan Hsu Breakdown of academic impact, for papers by Hyun Yang
Rankless by CCL
2026